Highly effective drugs that currently lie for the most part in Italian hospital pharmacies. “Resuming the process of eradication of Hepatitis C – explains Professor Msssimo Galli of the Sacco Hospital in Milan – means not only resuming the assistance activity, but also the commitment aimed at favoring the emergence of the submerged and the treatment of people with active infection.
After a reduction of more than 90% during the lockdown, the treatments still struggle to resume at the previous pace, despite almost 3 months have passed since May 4, considered the start of Phase 2. Furthermore, the summer season is not conducive to a rapid recovery: the health personnel are very tried by what has happened in recent months and, even in anticipation of a difficult autumn, they will also have to take a break. an incisive action to search for the undeclared “.
DON’T FORGET ABOUT HEPATITIS B
But the day of July 28 provides an opportunity to tackle the situation relating to other hepatitis as well. The pandemic, in fact, has affected every area and has made treatment interventions less efficient and, perhaps, the extension of vaccination procedures for hepatitis B.
To combat this disease, an effective vaccine is first available, to which are added discrete therapeutic tools. “We must continue to ensure broad vaccination coverage, relieving interventions after the blow suffered by the health system with the pandemic and reconnect with patients, who are often on chronic antiviral therapy, ensuring maintenance in treatment” concludes Galli.
World Hepatitis Day is celebrated today in the world, the world day that draws attention to an infectious disease which, according to data from the World Health Organization, kills 1.4 million people a year.
A total of 10 million people with chronic hepatitis B and C are often not even aware of it. There is therefore a need to intensify the prevention action but also to ensure the best treatments for people who have contracted the infection.
An issue that also affects a large segment of the population in Europe where, according to the estimates of the European Center for Diseases Control and Prevention (Ecdc), the virus is returning to take on the appearance of a public health challenge that affects many countries.
In 2013, nearly 20,000 cases of hepatitis B were registered in the 28 of the EU, while over 32,000 cases of hepatitis C occurred in 26 countries. Hepatitis A also became threatening in 2014, also thanks to travel to endemic areas and the consumption of contaminated food; in 2015 there were 1,500 cases.
The importance of prevention therefore appears decisive and is also the motto that inspires the day (Get tested, seek treatment): according to the WHO in 80% hepatitis B and C are the basis of the very heavy consequence of liver cancer.
Particular attention is paid to Egypt in the 2015 edition: hepatitis C affects 10% of the population between 15 and 59 years of age. Obviously, the challenge for prevention will then become particularly intense in the country, which is also the recipient of the WHO pilot initiative, or the Global Injection Safety Initiative.